Association of serum Dkk-1 levels with β-catenin in patients with postmenopausal osteoporosis

Jun Tian,Xiao-juan Xu,Lin Shen,Yan-ping Yang,Rui Zhu,Bo Shuai,Xi-Wen Zhu,Cheng-gang Li,Chen Ma,Lin Lv
DOI: https://doi.org/10.1007/s11596-015-1413-6
2015-01-01
Journal of Huazhong University of Science and Technology [Medical Sciences]
Abstract:Summary Wnt signaling plays an important role in the bone development and remodeling. The Wnt antagonist Dkk-1 is a potent inhibitor of bone formation. The aims of this study were firstly to compare the serum Dkk-1 levels in postmenopausal osteoporosis patients with age-matched healthy controls, and secondly, to assess the possible relationship between Dkk-1 and β-catenin, sclerostin, or bone turnover markers [CTX, PINP, N-MID-OT and 25(OH)D] in the setting of postmenopausal osteoporosis. A total of 350 patients with postmenopausal osteoporosis and 150 age-matched healthy controls were enrolled, and the serum levels of Dkk-1, β-catenin, sclerostin, OPG, and RANKL were detected by ELISA, and bone turnover markers [CTX, PINP, N-MID-OT and 25(OH)D] were measured by Roche electrochemiluminescence system in two groups. Serum Dkk-1 levels were significantly higher in postmenopausal osteoporosis group than in control group ( P <0.001). Univariate analyses revealed that serum Dkk-1 levels were weakly negatively correlated to β-catenin ( r =−0.161, P =0.003) and OPG ( r =−0.106, P =0.047), while multiple regression analysis showed a negative correlation between serum Dkk-1 levels with β-catenin (β=−0.165, P =0.009) and BMD (β=−0.139, P =0.027), and a positive correlation between serum Dkk-1 levels and CTX (β=0.122, P =0.040) in postmenopausal osteoporosis group. No similar correlations ware observed in control group. The results provided evidence for the role of Dkk-1 in bone metabolism and demonstrated the link of Dkk-1 and Wnt/β-catenin in some ways.
What problem does this paper attempt to address?